PhaseBio Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
THORP CLAY director
 Common Stock 400 $14 $5,600
Sale
THORP CLAY director
 Common Stock 400 $14 $5,600
Sale
THORP CLAY director
 Common Stock 400 N/A N/A
Option
SHARP JOHN P officer: Chief Financial Officer
 Employee Stock Option (right to buy) 15,000 N/A N/A
Option
SHARP JOHN P officer: Chief Financial Officer
 Common Stock 15,000 N/A N/A
Option
MOW JONATHAN P director, officer: Chief Execut..
 Employee stock option (right to buy) 19,131 N/A N/A
Option
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 19,131 N/A N/A
Option
MOW JONATHAN P director, officer: Chief Execut..
 Employee stock option (right to buy) 19,913 N/A N/A
Option
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 19,913 N/A N/A
Purchase
HUTSON NANCY J director
 Common Stock 1,000 N/A N/A
Purchase
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 1,000 N/A N/A
Purchase
BALLANCE DAVID JAMES officer: VP, Research and Sci. ..
 Common Stock 1,000 N/A N/A
Purchase
YORK MICHAEL officer: VP, Corporate Developm..
 Common Stock 1,500 N/A N/A
Purchase
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 1,600 $3.85 $6,160
Purchase
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 1,600 N/A N/A
Purchase
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 2,900 $3.89 $11,267
Purchase
SHARP JOHN P officer: Chief Financial Officer
 Common Stock 5,000 N/A N/A
Purchase
MOW JONATHAN P director, officer: Chief Execut..
 Common Stock 2,900 N/A N/A
Purchase
THORP CLAY director
 Common Stock 4,000 N/A N/A
Purchase
HATTERAS VENTURE ADVISORS III, LLC 10 percent owner
 Common Stock 300,000 $5 $1,500,000
Option
THORP CLAY director
 Series B Preferred Stock 20,792 $0.06 $1,248
Option
TUFTS LINDA director
 Series B Preferred Stock 11,122 $0.04 $445
Option
ARNOLD SUSAN ELIZABETH officer: VP, Preclinical and Chem
 Series B Preferred Stock 103 N/A N/A
Option
ARNOLD SUSAN ELIZABETH officer: VP, Preclinical and Chem
 Warrants to Purchase Series B Preferred Stock 103 N/A N/A
Option
MOW JONATHAN P director, officer: Chief Execut..
 Series B Preferred Stock 310 N/A N/A
Option
MOW JONATHAN P director, officer: Chief Execut..
 Warrants to Purchase Series B Preferred Stock 310 N/A N/A
Option
TUFTS LINDA director
 Series C-1 Preferred Stock 15,528 N/A N/A
Sale
TUFTS LINDA director
 Series C-1 Preferred Stock 374 N/A N/A
Sale
TUFTS LINDA director
 Series B Preferred Stock 269 N/A N/A
Option
TUFTS LINDA director
 Series B Preferred Stock 11,122 N/A N/A
Purchase
TUFTS LINDA director
 Common Stock 20,000 N/A N/A
Sale
THORP CLAY director
 Series C-1 Preferred Stock 2,237 N/A N/A
Option
THORP CLAY director
 Series C-1 Preferred Stock 93,181 N/A N/A
Sale
THORP CLAY director
 Series B Preferred Stock 500 N/A N/A
Option
THORP CLAY director
 Series B Preferred Stock 20,792 N/A N/A
Purchase
THORP CLAY director
 Common Stock 300,000 N/A N/A
Sale
KLEIN PETER JUSTIN director
 Series B Preferred Stock 3 N/A N/A
Sale
ASTRAZENECA PLC 10 percent owner
 Series C-1 Preferred Stock 2,734 N/A N/A
Sale
HATTERAS VENTURE ADVISORS III, LLC 10 percent owner
 Series C-1 Preferred Stock 2,237 N/A N/A
Purchase
HATTERAS VENTURE ADVISORS III, LLC 10 percent owner
 Common Stock 300,000 N/A N/A
Option
TUFTS LINDA director
 Warrants to Purchase Series B Preferred Stock 7,053 N/A N/A
Option
THORP CLAY director
 Warrants to Purchase Series B Preferred Stock 19,061 N/A N/A
Purchase
ASTRAZENECA PLC 10 percent owner
 Common Stock 600,000 N/A N/A
Sale
NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner
 Series C-1 Preferred Stock 4,349 N/A N/A
Sale
NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner
 Series B Preferred Stock 1,177 N/A N/A
Purchase
NEW ENTERPRISE ASSOCIATES 13 LP 10 percent owner
 Common Stock 1,800,000 N/A N/A
Sale
HATTERAS VENTURE ADVISORS III, LLC 10 percent owner
 Series B Preferred Stock 500 N/A N/A

Showing 50 to 97 of 97 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: